Gregg Eure, MD

Articles by Gregg Eure, MD

Making Sense of the Reintervention Rate for BPH

ByGregg Eure, MD,LAURENCE A. LEVINE, MD

March 7th 2021

Letter: BPH guidelines may ignore FDA, insurance criteria

ByGregg Eure, MD

May 12th 2020

"As we seek to understand MIST retreatment rates, as Houlihan and Köhler suggest, we must rely upon real-world population data," writes Gregg Eure, MD, in a letter to the editor.

Latest Updated Articles

Making Sense of the Reintervention Rate for BPH
Published: March 7th 2021 | Updated:
Letter: BPH guidelines may ignore FDA, insurance criteria
Published: May 12th 2020 | Updated:

Gregg Eure, MD

Articles by Gregg Eure, MD

Making Sense of the Reintervention Rate for BPH

Letter: BPH guidelines may ignore FDA, insurance criteria

Latest Updated Articles

Trending on Urology Times

FDA approves sildenafil oral film for men with erectile dysfunction

The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD

Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC

Pearls & Perspectives: Modern Semen Testing and Male Fertility Care, with Thomas Masterson, MD

URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues